<DOC>
	<DOCNO>NCT00250445</DOCNO>
	<brief_summary>The study design compare risk cardiovascular event ( heart attack , stroke ) patient receive either etoricoxib diclofenac . It also compare gastrointestinal tolerability two medicine . The study conduct patient either rheumatoid osteo-arthritis .</brief_summary>
	<brief_title>A Study Evaluate Safety Investigational Drug ( Etoricoxib ) Patients With Osteoarthritis ( OA ) Rheumatoid Arthritis ( RA ) ( 0663-066 )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<criteria>Patient clinical diagnosis either Osteoarthritis Rheumatoid Arthritis opinion investigator require chronic nonsteroidal antiinflammatory COX2 inhibitor therapy least 1.5 year Concurrent medical arthritic disease could confound interfere efficacy evaluation . Concomitant therapy warfarin , heparin , highdose aspirin ( &gt; 100 mg/day ) . Impaired kidney function , clinical gastrointestinal malabsorption , congestive heart failure symptom occur rest , unstable angina , uncontrolled high blood pressure , active hepatitis/hepatic disease</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Arcoxia</keyword>
</DOC>